These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 22905183)
1. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies. Wang YQ; Qi XW; Wang F; Jiang J; Guo QN PLoS One; 2012; 7(8):e42899. PubMed ID: 22905183 [TBL] [Abstract][Full Text] [Related]
2. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls. Liao RY; Mao C; Qiu LX; Ding H; Chen Q; Pan HF Mol Biol Rep; 2010 Oct; 37(7):3227-32. PubMed ID: 19882361 [TBL] [Abstract][Full Text] [Related]
3. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis. Zhang X; Wu L; Sheng Y; Zhou W; Huang Z; Qu J; Gao G; Cai D; Zhang M Mol Biol Rep; 2012 Mar; 39(3):2567-74. PubMed ID: 21858550 [TBL] [Abstract][Full Text] [Related]
4. Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study. Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA BMC Cancer; 2010 Apr; 10():169. PubMed ID: 20429896 [TBL] [Abstract][Full Text] [Related]
5. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study. Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729 [TBL] [Abstract][Full Text] [Related]
7. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241 [TBL] [Abstract][Full Text] [Related]
8. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer. Colleran G; McInerney N; Rowan A; Barclay E; Jones AM; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E Breast Cancer Res Treat; 2010 Jan; 119(2):437-42. PubMed ID: 19390964 [TBL] [Abstract][Full Text] [Related]
9. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies. Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057 [TBL] [Abstract][Full Text] [Related]
10. TGFBR1 polymorphism and risk of breast cancer in Iranian women. Kamali E; Hemmati S; Safari F; Tavassoli M Int J Biol Markers; 2015 Nov; 30(4):e414-7. PubMed ID: 26165686 [TBL] [Abstract][Full Text] [Related]
11. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer. Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956 [TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma. Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915 [TBL] [Abstract][Full Text] [Related]
13. Somatic acquisition and signaling of TGFBR1*6A in cancer. Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663 [TBL] [Abstract][Full Text] [Related]
14. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Skoglund Lundin J; Vandrovcova J; Song B; Zhou X; Zelada-Hedman M; Werelius B; Houlston RS; Lindblom A Br J Cancer; 2009 May; 100(10):1674-9. PubMed ID: 19401691 [TBL] [Abstract][Full Text] [Related]
15. TGFBR1*6A polymorphism in sporadic and familial colorectal Carcinoma: a case-control study and systematic literature review. Ibrahim T; Yazbeck C; Maalouly G; Baz M; Haddad F; Sabbagh C; Chahine G J Gastrointest Cancer; 2014 Dec; 45(4):441-7. PubMed ID: 24880985 [TBL] [Abstract][Full Text] [Related]
16. TGFBR1 haplotypes and risk of non-small-cell lung cancer. Lei Z; Liu RY; Zhao J; Liu Z; Jiang X; You W; Chen XF; Liu X; Zhang K; Pasche B; Zhang HT Cancer Res; 2009 Sep; 69(17):7046-52. PubMed ID: 19690145 [TBL] [Abstract][Full Text] [Related]
17. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of transforming growth factor β receptor I 6A/9A gene polymorphism and breast cancer risk: the picture remains murky. Ou C; Li H; Liu JH; Drummen GP; Zhu B; Huang LS; Huang Y; Li LQ Biomarkers; 2015; 20(6-7):487-94. PubMed ID: 26616150 [TBL] [Abstract][Full Text] [Related]
19. Association between Int7G24A rs334354 polymorphism and cancer risk: a meta-analysis of case-control studies. Wu W; Tong Y; Wei X; Zhao Q; Pan X; Yu G; Lu Q Sci Rep; 2015 Jun; 5():11350. PubMed ID: 26074400 [TBL] [Abstract][Full Text] [Related]
20. No association between TGFBR1*6A and lung cancer. You W; Liu Z; Zhao J; Zheng M; Zheng SY; Liu X; Zhang HT J Thorac Oncol; 2007 Jul; 2(7):657-9. PubMed ID: 17607123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]